FDA clears expansion of Luminopia amblyopia treatment to include 8 to 12 year old patients

Published on April 30, 2025
This expansion marks the first FDA clearance for an amblyopia treatment for this age range in more than 2 decades.
Continue reading on website
Other news

ASCRS 2025: Enhancing patient outcomes with presbyopia-correcting IOLs

April 30, 2025
At ASCRS 2025, Alex Hacopian, MD, shares information from his presentation on next-gen presbyopia-correcting intraocular lenses.

Does alcohol affect macular degeneration?

April 30, 2025
The leading source of breaking news, news analysis, and emerging research reports in optometry, Optometry Times® disseminates practical content by optometrists for optometrists that can be immediately applied to improve the clinical experience.